Sonoma Pharmaceuticals Announces Newly Published Results from Study of Hypochlorous Acid in Management of Hypertrophic and Keloid Scars

    NEXT STORY
    Moleculin Announces Positive Data on WP1066 in Pre-Clinical Trials
    PREV STORY
    Shire Files Submission for U.S. FDA Approval to Manufacture FLEXBUMIN® at New Plasma Manufacturing Facility near Covington, Georgia
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Roche receives CE Mark for its Accu-Chek Solo micropump system

    The Accu-Chek Solo micropump is a small, tube-free insulin delivery system that offers users ...

    author_avatar
    NASDAQ Market News

    Iterum Therapeutics Announces Topline Results from its Phase 3 Clinical Trial of Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections

    author_avatar
    NASDAQ Market News

    VIFOR PHARMA CONCLUDES LICENSING AGREEMENT WITH ZERIA TO MARKET VELTASSA® IN JAPAN

    Vifor Pharma gives Zeria exclusive rights to develop and market Veltassa® in Japan Potential ...

    author_avatar
    NASDAQ Market News